In colorectal cancer, the molecule network IGF1-HOXA13-ACLY/IGF1R and CXCL12-HOXB5-CXCR4/ITGB3, targeted blocking the downstream protein with small molecular compounds serves as a promising anticancer therapy (133, 134). Here, ACLY is linked to colorectal cancer.